The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments for cancers, cystic fibrosis, and rare diseases.

The Trump administration’s COVID-revenge campaign has laid the groundwork for Kennedy’s larger agenda.

HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door open to mRNA therapies for cancer and genetic conditions.